Cargando…
Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity
BACKGROUND: Breast cancer is the most common female cancer worldwide. Effective therapies including doxorubicin and trastuzumab have improved survival, but are associated with a substantial risk of cardiovascular disease. Mechanisms underlying cancer treatment-induced cardiotoxicity (CTC) are poorly...
Autores principales: | Hoffman, Rebecca K., Kim, Bang-Jin, Shah, Payal D., Carver, Joseph, Ky, Bonnie, Ryeom, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054404/ https://www.ncbi.nlm.nih.gov/pubmed/33875012 http://dx.doi.org/10.1186/s40959-021-00100-3 |
Ejemplares similares
-
Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
por: Truitt, Rachel, et al.
Publicado: (2018) -
Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
por: Hahn, Virginia Shalkey, et al.
Publicado: (2014) -
How to Apply Translational Models to Probe Mechanisms of Cardiotoxicity
por: Livingston, Carissa E., et al.
Publicado: (2022) -
Sustained Increases in IGFBP-7 May Be Related to Doxorubicin in Breast Cancer Patients
por: Wilcox, Nicholas S., et al.
Publicado: (2021) -
Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab
por: Demissei, Biniyam G., et al.
Publicado: (2020)